612 F.Supp.2d 421 (D.Vt. 2008), 2:07-cv-82, Kellogg v. Wyeth
Linked as:
Extract
612 F.Supp.2d 421 (D.Vt. 2008), 2:07-cv-82, Kellogg v. Wyeth
No longer available (Autolink)
See the full content of this document
This document cites
- Code of Federal Regulations - Advisory opinions
- Code of Federal Regulations - Requirements on content and format of labeling for human prescription drug and biological products
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products described in section 201.56(b)(1)
- Code of Federal Regulations - Specific requirements on content and format of labeling for human prescription drug and biological products; older drugs not described in section 201.56(b)(1)
- Code of Federal Regulations - Supplements and other changes to an approved NDA